Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Lind

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusionB M Cantwell, M Idle, M J Millward, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionM J Lind, J M Margison, T Cerny, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposideH Anderson, M J Lind, N Thatcher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
Hematological Oncology|January 1, 1989
Cyclosporin associated demyelination following allogeneic bone marrow transplantationM J Lind, L McWilliam, J Jip, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1989
The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancerJ Mackintosh, C H Buckley, V R Tindall, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursH D Thomas, M J Lind, J Ford, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancerM J Lind, S Gomm, A P Simmonds, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pumpJ A Radford, J M Margison, R Swindell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pumpJ A Radford, J M Margison, R Swindell, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusionB M Cantwell, M Idle, M J Millward, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionM J Lind, J M Margison, T Cerny, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposideH Anderson, M J Lind, N Thatcher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
Hematological Oncology|January 1, 1989
Cyclosporin associated demyelination following allogeneic bone marrow transplantationM J Lind, L McWilliam, J Jip, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1989
The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancerJ Mackintosh, C H Buckley, V R Tindall, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursH D Thomas, M J Lind, J Ford, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancerM J Lind, S Gomm, A P Simmonds, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pumpJ A Radford, J M Margison, R Swindell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pumpJ A Radford, J M Margison, R Swindell, et al.
Pageof 5